Sıçanlarda Asetik Asit ile Oluşturulmuş Deneysel Ülseratif Kolitis Modelinde Zingeron’un Etkilerinin Araştırılması

Bu çalışmada asetik asit ile oluşturulmuş deneysel ülseratif kolitis modelinde zingeron’un etkileri araştırıldı. Bu amaçla her grupta 7 sıçan olacak şekilde 4 grupta çalışma yapıldı. Gruplar; kontrol (serum fizyolojik - intrarektal), kolitis (%3 asetik asit - intrarektal), sülfasalazin (50 mg/kg) + kolitis (%3 asetik asit - intrarektal) ve zingeron (20 mg/kg) + kolitis (%3 asetik asit - intrarektal) olacak şekilde oluşturuldu. Elde edilen verilere göre, kolitis oluşturulan grupta kontrol grubuna göre malondialdehit (MDA) seviyeleri artış göstermiş (P

Investigation of the Effects of Zingeron on Acetic Acid – Induced Experimental Ulcerative Colitis Model in Rats

In this study, the effects of zingeron on acetic acid induced ulcerative colitis model were investigated. For this purpose, 4 groups were studied with 7 rats in each group. Groups were; control (serum physiological - intrarectal), colitis (3% acetic acid - intrarectal), sulfasalazine (50 mg/kg) + colitis (3% acetic acid - intrarectal) and group-4; zingerone (20 mg/kg) + colitis (3% acetic acid - intrarectal). According to the results, malondialdehyde (MDA) levels increased (P

PDF

___

1. Moura FA, de Andrade KQ, Dos Santos JCF, Araújo ORP, Goulart MOF. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox biology 2015; 6: 617-639.
2. Yadav V, Varum F, Bravo R, et al. Inflammatory bowel disease: Exploring gut pathophysiology for novel therapeutic targets. Translational Research 2016; 176: 3868.
3. Nowarski R, Jackson R, Gagliani N, et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 2015; 163: 1444-1456.
4. Abraham C, Cho JH, Mechanisms of disease. N Engl J Med 2009; 361: 2066-2078.
5. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Archives of Biochemistry and Biophysics 2004; 423: 12-22.
6. Hyun JG, Mayer L. Mechanisms underlying inflammatory bowel disease. Drug Discovery Today: Disease Mechanisms 2006; 3: 457-462.
7. Sales-Campos H, Basso P, Alves V, et al. Classical and recent advances in the treatment of inflammatory bowel diseases. Brazilian Journal of Medical and Biological Research 2015; 48: 96-107.
8. McLean LP, Cross RK. Adverse events in IBD: To stop or continue immune suppressant and biologic treatment. Expert Review of Gastroenterology & Hepatology 2014; 8: 223-240.
9. Gilardi D, Fiorino G, Genua M, Allocca M, Danese S, Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine? Expert Review of Gastroenterology & Hepatology 2014; 8: 835-846.
10. Esters P, Dignass A. Complementary therapies in inflammatory bowel diseases. Current Drug Targets 2014; 15: 1079-1088.
11. Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food and Chemical Toxicology 2007; 45: 683-690.
12. Mani V, Arivalagan S, Siddique AI, Namasivayam N. Antioxidant and anti-inflammatory role of zingerone in ethanol-induced hepatotoxicity. Molecular and Cellular Biochemistry 2016; 421: 169-181.
13. Mani V, Arivalagan S, Siddique AI, Namasivayam N. Antihyperlipidemic and antiapoptotic potential of zingerone on alcohol induced hepatotoxicity in experimental rats. Chemico-Biological Interactions 2017; 272: 197-206.
14. Ahmad B, Rehman MU, Amin I, et al. A review on pharmacological properties of zingerone (4-(4-Hydroxy-3methoxyphenyl)-2-butanone). The Scientific World Journal 2015; 2015.
15. Caglayan C, Kandemir FM, Yıldırım S, et al. Zingerone ameliorates cisplatin‐induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and apoptosis in female wistar rats. Biomedicine & Pharmacotherapy 2018; 102: 517-530.
16. Coppola G, Novo S. Statins and peripheral arterial disease: Effects on claudication, disease progression, and prevention of cardiovascular events. Archives of Medical Research 2007; 38: 479-488.
17. Taslimi P, Caglayan C, Gulcin I. The impact of some natural phenolic compounds on carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and αglycosidase enzymes: An antidiabetic, anticholinergic, and antiepileptic study. Journal of Biochemical and Molecular Toxicology 2017; 31: e21995.
18. Soliman N, Keshk W, Rizk F, Ibrahim M. The possible ameliorative effect of simvastatin versus sulfasalazine on acetic acid induced ulcerative colitis in adult rats. Chemico-Biological Interactions 2019; 298: 57-65.
19. Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Analytical Biochemistry 1966; 16: 359-364.
20. Sedlak, J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 1968; 25: 192-205.
21. Aebi H. Catalase. In: Bergmeyer HU. (Editor). Methods of Enzymatic Analysis. Weinheim / NewYork: Verlag Chemie/Academic Press Inc, 1974: 673-680.
22. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochemical and Biophysical Research Communications 1976; 71: 952-958.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265-275.
24. Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D. Experimental colitis in rats with portal hypertension and liver disease. Inflammatory Bowel Diseases 2003; 9: 1824.
25. Uzunismail H, Hatemi I, Doğusoy G, Akin O. Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: Report of two cases. The Turkish Journal of Gastroenterology: The official Journal of Turkish Society of Gastroenterology 2006; 17: 53-57.
26. Yang M, Yao Y, Eades G, Zhang Y, Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Research and Treatment 2011; 129: 983-991.
27. Bernstein CN. Treatment of IBD: Where we are and where we are going. The American Journal of Gastroenterology 2015; 110: 114.
28. Bressler B, Marshall JK, Bernstein CN, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The Toronto consensus. Gastroenterology 2015; 148: 1035-1058.
29. Siegel C. explaining risks of inflammatory bowel disease therapy to patients. Alimentary Pharmacology & Therapeutics 2011; 33: 23-32.
30. Hur SJ, Kang SH, Jung HS, et al. Review of natural products actions on cytokines in inflammatory bowel disease. Nutrition Research 2012; 32: 801-816.
31. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Design, Development and Therapy 2013; 7: 1341.
32. Loguercio C, D'Argenio G, Delle Cave M, et al. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Digestive Diseases and Sciences 1996; 41: 1204-1211.
33. Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: Updated experimental and clinical evidence. Experimental Biology and Medicine 2012; 237: 474-480.
34. Sepehrimanesh M, Samimi N, Koohi-Hosseinabadi O, et al. Effects of cupressus sempervirens extract on the healing of acetic acid-induced ulcerative colitis in rat. Journal of Coloproctology 2018; 38: 309-313.
35. Amirshahrokhi K, Bohlooli S, Chinifroush M. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicology and Applied Pharmacology 2011; 253: 197202.
36. Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, et al. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World Journal of Gastroenterology: WJG 2013; 19: 5633.
37. Tekeli İO, Ateşşahin A, Sakin F, et al. Protective effects of conventional and colon-targeted lycopene and linalool on ulcerative colitis induced by acetic acid in rats. Inflammopharmacology 2019; 27: 313-322.
38. Almeer RS, Mahmoud SM, Amin HK, Moneim AEA. Ziziphus spina-christi fruit extract suppresses oxidative stress and p38 MAPK expression in ulcerative colitis in rats via induction of Nrf2 and HO-1 expression. Food and Chemical Toxicology 2018; 115: 49-62.
39. Güvenç M, Cellat M, Özkan H, et al. Protective effects of tyrosol against DSS-induced ulcerative colitis in rats. Inflammation 2019: 42:1680-1691.
40. Murad HA, Abdallah HM, Ali SS. Mentha longifolia protects against acetic-acid induced colitis in rats. Journal of Ethnopharmacology 2016; 190: 354-361.
41. Rezaei N, Eftekhari MH, Tanideh N, Mokhtari M, Bagheri Z. Comparison of antioxidant and anti-inflammatory effects of honey and spirulina platensis with sulfasalazine and mesalazine on acetic acid-induced ulcerative colitis in rats. Galen Medical Journal 2019; 8: 1095.
42. Millar A, Rampton D, Chander C, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996; 39: 407-415.
43. Choudhary S, Keshavarzian A, Yong S, et al. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Digestive Diseases and Sciences 2001; 46: 22222230.
44. Somani S, Badgujar L, Sutariya B, Saraf M. Protective effect of Dillenia indica L. on acetic acid induced colitis in mice. Indian Journal of Experimental Biology 2014; 52: 876-881.
45. Dugani A, Dakhil B, Treesh S. Protective effect of the methanolic extract of malva parviflora l. leaves on acetic acid-induced ulcerative colitis in rats. Saudi journal of Gastroenterology: Official Journal of The Saudi Gastroenterology Association 2016; 22: 226.
46. Bastaki SM, Adeghate E, Amir N, Ojha S, Oz M. Menthol inhibits oxidative stress and inflammation in acetic acidinduced colitis in rat colonic mucosa. American Journal of Translational Research 2018; 10: 4210.
47. Palla AH, Iqbal NT, Minhas K, Gilani AH. Flaxseed extract exhibits mucosal protective effect in acetic acid induced colitis in mice by modulating cytokines, antioxidant and antiinflammatory mechanisms. International Immunopharmacology 2016; 38: 153-166.
48. Uyar A, Emlik H, Yaman T. Effect of high carbohydrate, fat and intermittent fasting diet on experimental ulcerative colitis. Harran Üniversitesi Veteriner Fakültesi Dergisi 2018; 7: 7-14.
49. Baykalir BG, Aksit D, Dogru MS, et al. Lycopene ameliorates experimental colitis in rats via reducing apoptosis and oxidative stress. Int J Vitam Nutr Res 2016; 86: 27-35.
50. Martín AR, Villegas I, Sánchez‐Hidalgo M, De La Lastra CA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. British Journal of Pharmacology 2006; 147: 873-885.
51. Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: Epidemiology, clinical features, and current management. Therapeutic Advances in Gastroenterology 2011; 4: 301309.